ffeng	10.1200/JCO.2017.35.15_suppl.e12102	<http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12102>; rel="canonical"	<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:j.0="http://purl.org/dc/terms/" xmlns:j.1="http://prismstandard.org/namespaces/basic/2.1/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:j.2="http://purl.org/ontology/bibo/" xmlns:j.3="http://xmlns.com/foaf/0.1/"><rdf:Description rdf:about="http://dx.doi.org/10.1200/JCO.2017.35.15_suppl.e12102"><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/benjamin-chandler-swkrboijd90j"><j.3:name>Benjamin Chandler</j.3:name><j.3:familyName>Chandler</j.3:familyName><j.3:givenName>Benjamin</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/shuang-zhao-swkrboijd90j"><j.3:name>Shuang Zhao</j.3:name><j.3:familyName>Zhao</j.3:familyName><j.3:givenName>Shuang</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/eric-olsen-swkrboijd90j"><j.3:name>Eric Olsen</j.3:name><j.3:familyName>Olsen</j.3:familyName><j.3:givenName>Eric</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/felix-yi-chung-feng-swkrboijd90j"><j.3:name>Felix Yi-Chung Feng</j.3:name><j.3:familyName>Feng</j.3:familyName><j.3:givenName>Felix Yi-Chung</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/lori-j-pierce-swkrboijd90j"><j.3:name>Lori J. Pierce</j.3:name><j.3:familyName>Pierce</j.3:familyName><j.3:givenName>Lori J.</j.3:givenName></j.3:Person></j.0:creator><j.1:volume>35</j.1:volume><j.1:endingPage>e12102</j.1:endingPage><j.2:doi>10.1200/jco.2017.35.15_suppl.e12102</j.2:doi><j.0:publisher>American Society of Clinical Oncology (ASCO)</j.0:publisher><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/daniel-richard-wahl-swkrboijd90j"><j.3:name>Daniel Richard Wahl</j.3:name><j.3:familyName>Wahl</j.3:familyName><j.3:givenName>Daniel Richard</j.3:givenName></j.3:Person></j.0:creator><j.0:date rdf:datatype="http://www.w3.org/2001/XMLSchema#date" >2017-05-20</j.0:date><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/james-m-rae-swkrboijd90j"><j.3:name>James M. Rae</j.3:name><j.3:familyName>Rae</j.3:familyName><j.3:givenName>James M.</j.3:givenName></j.3:Person></j.0:creator><j.0:isPartOf><j.2:Journal rdf:about="http://id.crossref.org/issn/0732-183X"><j.1:issn>1527-7755</j.1:issn><j.2:issn>1527-7755</j.2:issn><owl:sameAs>urn:issn:1527-7755</owl:sameAs><owl:sameAs>urn:issn:0732-183X</owl:sameAs><j.0:title>Journal of Clinical Oncology</j.0:title><j.1:issn>0732-183X</j.1:issn><j.2:issn>0732-183X</j.2:issn></j.2:Journal></j.0:isPartOf><j.2:pageEnd>e12102</j.2:pageEnd><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/daniel-eidelberg-spratt-swkrboijd90j"><j.3:name>Daniel Eidelberg Spratt</j.3:name><j.3:familyName>Spratt</j.3:familyName><j.3:givenName>Daniel Eidelberg</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/corey-wayne-speers-swkrboijd90j"><j.3:name>Corey Wayne Speers</j.3:name><j.3:familyName>Speers</j.3:familyName><j.3:givenName>Corey Wayne</j.3:givenName></j.3:Person></j.0:creator><j.0:identifier>10.1200/jco.2017.35.15_suppl.e12102</j.0:identifier><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/daniel-f-hayes-swkrboijd90j"><j.3:name>Daniel F. Hayes</j.3:name><j.3:familyName>Hayes</j.3:familyName><j.3:givenName>Daniel F.</j.3:givenName></j.3:Person></j.0:creator><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/shyam-nyati-swkrboijd90j"><j.3:name>Shyam Nyati</j.3:name><j.3:familyName>Nyati</j.3:familyName><j.3:givenName>Shyam</j.3:givenName></j.3:Person></j.0:creator><j.2:pageStart>e12102</j.2:pageStart><owl:sameAs rdf:resource="http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e12102"/><owl:sameAs rdf:resource="info:doi/10.1200/jco.2017.35.15_suppl.e12102"/><j.1:doi>10.1200/jco.2017.35.15_suppl.e12102</j.1:doi><j.0:title>Radiosensitization of androgen receptor (AR)-positive triple-negative breast cancer (TNBC) cells using seviteronel (SEVI), a selective CYP17 lyase and AR inhibitor.</j.0:title><j.2:volume>35</j.2:volume><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/kari-wilder-romans-swkrboijd90j"><j.3:name>Kari Wilder-Romans</j.3:name><j.3:familyName>Wilder-Romans</j.3:familyName><j.3:givenName>Kari</j.3:givenName></j.3:Person></j.0:creator><owl:sameAs rdf:resource="doi:10.1200/jco.2017.35.15_suppl.e12102"/><j.0:creator><j.3:Person rdf:about="http://id.crossref.org/contributor/meilan-liu-swkrboijd90j"><j.3:name>Meilan Liu</j.3:name><j.3:familyName>Liu</j.3:familyName><j.3:givenName>Meilan</j.3:givenName></j.3:Person></j.0:creator><j.1:startingPage>e12102</j.1:startingPage></rdf:Description></rdf:RDF>
